nodes	percent_of_prediction	percent_of_DWPC	metapath
Mercaptopurine—PPAT—Fluorouracil—skin cancer	0.442	0.552	CbGbCtD
Mercaptopurine—SLC29A1—Fluorouracil—skin cancer	0.169	0.211	CbGbCtD
Mercaptopurine—ABCC5—Fluorouracil—skin cancer	0.129	0.161	CbGbCtD
Mercaptopurine—ABCC4—Fluorouracil—skin cancer	0.0619	0.0773	CbGbCtD
Mercaptopurine—SLC28A3—nipple—skin cancer	0.00371	0.0658	CbGeAlD
Mercaptopurine—HPRT1—hair follicle—skin cancer	0.00369	0.0655	CbGeAlD
Mercaptopurine—Polyp—Vemurafenib—skin cancer	0.00342	0.0256	CcSEcCtD
Mercaptopurine—PPAT—nipple—skin cancer	0.00326	0.0579	CbGeAlD
Mercaptopurine—Cyst—Vemurafenib—skin cancer	0.00311	0.0233	CcSEcCtD
Mercaptopurine—Skin hyperpigmentation—Imiquimod—skin cancer	0.00298	0.0223	CcSEcCtD
Mercaptopurine—ABCC5—hair follicle—skin cancer	0.0027	0.0479	CbGeAlD
Mercaptopurine—Hepatotoxicity—Vemurafenib—skin cancer	0.00269	0.0201	CcSEcCtD
Mercaptopurine—Myelosuppression—Bleomycin—skin cancer	0.00269	0.0201	CcSEcCtD
Mercaptopurine—Cyst—Imiquimod—skin cancer	0.00265	0.0198	CcSEcCtD
Mercaptopurine—Myelosuppression—Dactinomycin—skin cancer	0.00251	0.0187	CcSEcCtD
Mercaptopurine—HPRT1—nipple—skin cancer	0.0025	0.0444	CbGeAlD
Mercaptopurine—Myelosuppression—Temozolomide—skin cancer	0.00227	0.017	CcSEcCtD
Mercaptopurine—Breast disorder—Vismodegib—skin cancer	0.00221	0.0165	CcSEcCtD
Mercaptopurine—SLC28A3—mammalian vulva—skin cancer	0.00216	0.0384	CbGeAlD
Mercaptopurine—Skin hyperpigmentation—Bleomycin—skin cancer	0.00212	0.0158	CcSEcCtD
Mercaptopurine—Drug fever—Docetaxel—skin cancer	0.00212	0.0158	CcSEcCtD
Mercaptopurine—TPMT—nipple—skin cancer	0.00211	0.0375	CbGeAlD
Mercaptopurine—Myelosuppression—Fluorouracil—skin cancer	0.00209	0.0156	CcSEcCtD
Mercaptopurine—PPAT—mammalian vulva—skin cancer	0.00191	0.0338	CbGeAlD
Mercaptopurine—Neoplasm—Vemurafenib—skin cancer	0.00188	0.0141	CcSEcCtD
Mercaptopurine—Ulcer—Imiquimod—skin cancer	0.00188	0.014	CcSEcCtD
Mercaptopurine—HPRT1—connective tissue—skin cancer	0.00178	0.0315	CbGeAlD
Mercaptopurine—SLC29A2—female reproductive system—skin cancer	0.0017	0.0301	CbGeAlD
Mercaptopurine—SLC29A1—nipple—skin cancer	0.00168	0.0298	CbGeAlD
Mercaptopurine—Oral candidiasis—Temozolomide—skin cancer	0.00167	0.0125	CcSEcCtD
Mercaptopurine—Skin hyperpigmentation—Fluorouracil—skin cancer	0.00165	0.0123	CcSEcCtD
Mercaptopurine—PPAT—female reproductive system—skin cancer	0.00163	0.029	CbGeAlD
Mercaptopurine—HPRT1—skin of body—skin cancer	0.0016	0.0284	CbGeAlD
Mercaptopurine—AOX1—nipple—skin cancer	0.00157	0.0279	CbGeAlD
Mercaptopurine—Hepatotoxicity—Dactinomycin—skin cancer	0.00152	0.0114	CcSEcCtD
Mercaptopurine—Myelosuppression—Docetaxel—skin cancer	0.00151	0.0113	CcSEcCtD
Mercaptopurine—Alopecia—Vismodegib—skin cancer	0.00149	0.0112	CcSEcCtD
Mercaptopurine—PPAT—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00149	0.166	CbGpPWpGaD
Mercaptopurine—Malnutrition—Vismodegib—skin cancer	0.00147	0.011	CcSEcCtD
Mercaptopurine—HPRT1—mammalian vulva—skin cancer	0.00146	0.0259	CbGeAlD
Mercaptopurine—XDH—mammalian vulva—skin cancer	0.00144	0.0256	CbGeAlD
Mercaptopurine—Cholestasis—Temozolomide—skin cancer	0.0014	0.0105	CcSEcCtD
Mercaptopurine—Hepatotoxicity—Temozolomide—skin cancer	0.00138	0.0103	CcSEcCtD
Mercaptopurine—PPAT—head—skin cancer	0.00136	0.0242	CbGeAlD
Mercaptopurine—Ulcer—Bleomycin—skin cancer	0.00133	0.00996	CcSEcCtD
Mercaptopurine—HPRT1—lymphoid tissue—skin cancer	0.0013	0.023	CbGeAlD
Mercaptopurine—Liver injury—Temozolomide—skin cancer	0.00126	0.00945	CcSEcCtD
Mercaptopurine—Arthralgia—Vismodegib—skin cancer	0.00125	0.00937	CcSEcCtD
Mercaptopurine—HPRT1—female reproductive system—skin cancer	0.00125	0.0222	CbGeAlD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00124	0.00931	CcSEcCtD
Mercaptopurine—Ulcer—Dactinomycin—skin cancer	0.00124	0.00929	CcSEcCtD
Mercaptopurine—XDH—female reproductive system—skin cancer	0.00124	0.0219	CbGeAlD
Mercaptopurine—TPMT—mammalian vulva—skin cancer	0.00123	0.0219	CbGeAlD
Mercaptopurine—SLC29A1—connective tissue—skin cancer	0.00119	0.0211	CbGeAlD
Mercaptopurine—Skin hyperpigmentation—Docetaxel—skin cancer	0.00119	0.00889	CcSEcCtD
Mercaptopurine—Skin disorder—Vismodegib—skin cancer	0.00117	0.00873	CcSEcCtD
Mercaptopurine—Breast disorder—Imiquimod—skin cancer	0.00116	0.0087	CcSEcCtD
Mercaptopurine—Polyp—Docetaxel—skin cancer	0.00116	0.00869	CcSEcCtD
Mercaptopurine—Oral candidiasis—Docetaxel—skin cancer	0.00111	0.00832	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00109	0.00818	CcSEcCtD
Mercaptopurine—Mouth ulceration—Dactinomycin—skin cancer	0.00106	0.00795	CcSEcCtD
Mercaptopurine—Cyst—Docetaxel—skin cancer	0.00106	0.00791	CcSEcCtD
Mercaptopurine—Pancytopenia—Imiquimod—skin cancer	0.00106	0.0079	CcSEcCtD
Mercaptopurine—HPRT1—head—skin cancer	0.00105	0.0186	CbGeAlD
Mercaptopurine—Decreased appetite—Vismodegib—skin cancer	0.00104	0.00781	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00104	0.00776	CcSEcCtD
Mercaptopurine—Ulcer—Fluorouracil—skin cancer	0.00104	0.00774	CcSEcCtD
Mercaptopurine—Sepsis—Dactinomycin—skin cancer	0.00102	0.00763	CcSEcCtD
Mercaptopurine—Candida infection—Temozolomide—skin cancer	0.00102	0.00759	CcSEcCtD
Mercaptopurine—SLC29A2—lymph node—skin cancer	0.000992	0.0176	CbGeAlD
Mercaptopurine—SLC29A1—mammalian vulva—skin cancer	0.000982	0.0174	CbGeAlD
Mercaptopurine—Neoplasm—Temozolomide—skin cancer	0.000961	0.00719	CcSEcCtD
Mercaptopurine—PPAT—lymph node—skin cancer	0.000955	0.0169	CbGeAlD
Mercaptopurine—Hepatobiliary disease—Imiquimod—skin cancer	0.000939	0.00702	CcSEcCtD
Mercaptopurine—Alopecia—Vemurafenib—skin cancer	0.000923	0.0069	CcSEcCtD
Mercaptopurine—SLC29A1—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000921	0.103	CbGpPWpGaD
Mercaptopurine—AOX1—mammalian vulva—skin cancer	0.000918	0.0163	CbGeAlD
Mercaptopurine—Hepatotoxicity—Docetaxel—skin cancer	0.000916	0.00685	CcSEcCtD
Mercaptopurine—Malnutrition—Vemurafenib—skin cancer	0.000909	0.0068	CcSEcCtD
Mercaptopurine—TPMT—head—skin cancer	0.000882	0.0157	CbGeAlD
Mercaptopurine—SLC29A1—lymphoid tissue—skin cancer	0.000872	0.0155	CbGeAlD
Mercaptopurine—Sepsis—Fluorouracil—skin cancer	0.00085	0.00636	CcSEcCtD
Mercaptopurine—SLC29A1—female reproductive system—skin cancer	0.000841	0.0149	CbGeAlD
Mercaptopurine—Diarrhoea—Vismodegib—skin cancer	0.000822	0.00615	CcSEcCtD
Mercaptopurine—Immune system disorder—Imiquimod—skin cancer	0.000805	0.00602	CcSEcCtD
Mercaptopurine—Alopecia—Imiquimod—skin cancer	0.000787	0.00589	CcSEcCtD
Mercaptopurine—AOX1—female reproductive system—skin cancer	0.000786	0.0139	CbGeAlD
Mercaptopurine—Malnutrition—Imiquimod—skin cancer	0.000776	0.0058	CcSEcCtD
Mercaptopurine—Arthralgia—Vemurafenib—skin cancer	0.000774	0.00579	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000769	0.00575	CcSEcCtD
Mercaptopurine—Vomiting—Vismodegib—skin cancer	0.000764	0.00571	CcSEcCtD
Mercaptopurine—Rash—Vismodegib—skin cancer	0.000757	0.00566	CcSEcCtD
Mercaptopurine—Dermatitis—Vismodegib—skin cancer	0.000757	0.00566	CcSEcCtD
Mercaptopurine—Pancytopenia—Bleomycin—skin cancer	0.000751	0.00562	CcSEcCtD
Mercaptopurine—HPRT1—lymph node—skin cancer	0.000733	0.013	CbGeAlD
Mercaptopurine—Skin disorder—Vemurafenib—skin cancer	0.000721	0.00539	CcSEcCtD
Mercaptopurine—Nausea—Vismodegib—skin cancer	0.000714	0.00534	CcSEcCtD
Mercaptopurine—Hepatocellular injury—Docetaxel—skin cancer	0.000707	0.00529	CcSEcCtD
Mercaptopurine—SLC29A1—head—skin cancer	0.000702	0.0125	CbGeAlD
Mercaptopurine—Pancytopenia—Dactinomycin—skin cancer	0.0007	0.00524	CcSEcCtD
Mercaptopurine—Breast disorder—Temozolomide—skin cancer	0.000697	0.00522	CcSEcCtD
Mercaptopurine—Stomatitis—Bleomycin—skin cancer	0.000687	0.00514	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000676	0.00506	CcSEcCtD
Mercaptopurine—Candida infection—Docetaxel—skin cancer	0.000675	0.00505	CcSEcCtD
Mercaptopurine—Arthralgia—Imiquimod—skin cancer	0.00066	0.00494	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000656	0.0049	CcSEcCtD
Mercaptopurine—Decreased appetite—Vemurafenib—skin cancer	0.000645	0.00482	CcSEcCtD
Mercaptopurine—Stomatitis—Dactinomycin—skin cancer	0.000641	0.00479	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000641	0.00479	CcSEcCtD
Mercaptopurine—Neoplasm—Docetaxel—skin cancer	0.000639	0.00478	CcSEcCtD
Mercaptopurine—ABCC4—female reproductive system—skin cancer	0.000635	0.0113	CbGeAlD
Mercaptopurine—Pancytopenia—Temozolomide—skin cancer	0.000633	0.00474	CcSEcCtD
Mercaptopurine—Oedema—Imiquimod—skin cancer	0.000633	0.00473	CcSEcCtD
Mercaptopurine—TPMT—lymph node—skin cancer	0.000618	0.011	CbGeAlD
Mercaptopurine—Skin disorder—Imiquimod—skin cancer	0.000615	0.0046	CcSEcCtD
Mercaptopurine—Sepsis—Docetaxel—skin cancer	0.000614	0.00459	CcSEcCtD
Mercaptopurine—ABCC5—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00061	0.0681	CbGpPWpGaD
Mercaptopurine—Anorexia—Imiquimod—skin cancer	0.000603	0.00451	CcSEcCtD
Mercaptopurine—Body temperature increased—Vemurafenib—skin cancer	0.000587	0.00439	CcSEcCtD
Mercaptopurine—Pancytopenia—Fluorouracil—skin cancer	0.000584	0.00436	CcSEcCtD
Mercaptopurine—Stomatitis—Temozolomide—skin cancer	0.00058	0.00433	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000577	0.00431	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Temozolomide—skin cancer	0.000562	0.00421	CcSEcCtD
Mercaptopurine—Alopecia—Bleomycin—skin cancer	0.000559	0.00418	CcSEcCtD
Mercaptopurine—Decreased appetite—Imiquimod—skin cancer	0.00055	0.00411	CcSEcCtD
Mercaptopurine—Hypersensitivity—Vemurafenib—skin cancer	0.000547	0.00409	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000546	0.00409	CcSEcCtD
Mercaptopurine—ABCC5—lymph node—skin cancer	0.000536	0.0095	CbGeAlD
Mercaptopurine—Stomatitis—Fluorouracil—skin cancer	0.000534	0.00399	CcSEcCtD
Mercaptopurine—ABCC4—head—skin cancer	0.00053	0.00941	CbGeAlD
Mercaptopurine—SLC22A8—head—skin cancer	0.000526	0.00933	CbGeAlD
Mercaptopurine—PPAT—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000525	0.0586	CbGpPWpGaD
Mercaptopurine—Alopecia—Dactinomycin—skin cancer	0.000522	0.0039	CcSEcCtD
Mercaptopurine—Anaemia—Bleomycin—skin cancer	0.000509	0.00381	CcSEcCtD
Mercaptopurine—SLC28A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000509	0.0568	CbGpPWpGaD
Mercaptopurine—Diarrhoea—Vemurafenib—skin cancer	0.000508	0.0038	CcSEcCtD
Mercaptopurine—Body temperature increased—Imiquimod—skin cancer	0.0005	0.00374	CcSEcCtD
Mercaptopurine—Leukopenia—Bleomycin—skin cancer	0.000493	0.00369	CcSEcCtD
Mercaptopurine—SLC29A1—lymph node—skin cancer	0.000492	0.00873	CbGeAlD
Mercaptopurine—Immune system disorder—Temozolomide—skin cancer	0.000482	0.00361	CcSEcCtD
Mercaptopurine—Anaemia—Dactinomycin—skin cancer	0.000475	0.00355	CcSEcCtD
Mercaptopurine—Vomiting—Vemurafenib—skin cancer	0.000472	0.00353	CcSEcCtD
Mercaptopurine—Alopecia—Temozolomide—skin cancer	0.000472	0.00353	CcSEcCtD
Mercaptopurine—Rash—Vemurafenib—skin cancer	0.000468	0.0035	CcSEcCtD
Mercaptopurine—Dermatitis—Vemurafenib—skin cancer	0.000468	0.0035	CcSEcCtD
Mercaptopurine—Hypersensitivity—Imiquimod—skin cancer	0.000466	0.00349	CcSEcCtD
Mercaptopurine—Malnutrition—Temozolomide—skin cancer	0.000465	0.00348	CcSEcCtD
Mercaptopurine—Breast disorder—Docetaxel—skin cancer	0.000464	0.00347	CcSEcCtD
Mercaptopurine—Leukopenia—Dactinomycin—skin cancer	0.00046	0.00344	CcSEcCtD
Mercaptopurine—AOX1—lymph node—skin cancer	0.00046	0.00816	CbGeAlD
Mercaptopurine—Oedema—Bleomycin—skin cancer	0.00045	0.00336	CcSEcCtD
Mercaptopurine—Nausea—Vemurafenib—skin cancer	0.000441	0.0033	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Bleomycin—skin cancer	0.00044	0.00329	CcSEcCtD
Mercaptopurine—Alopecia—Fluorouracil—skin cancer	0.000435	0.00325	CcSEcCtD
Mercaptopurine—Diarrhoea—Imiquimod—skin cancer	0.000433	0.00324	CcSEcCtD
Mercaptopurine—Anaemia—Temozolomide—skin cancer	0.00043	0.00321	CcSEcCtD
Mercaptopurine—Anorexia—Bleomycin—skin cancer	0.000429	0.00321	CcSEcCtD
Mercaptopurine—ABCC4—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000423	0.0472	CbGpPWpGaD
Mercaptopurine—Pancytopenia—Docetaxel—skin cancer	0.000421	0.00315	CcSEcCtD
Mercaptopurine—Oedema—Dactinomycin—skin cancer	0.000419	0.00314	CcSEcCtD
Mercaptopurine—Leukopenia—Temozolomide—skin cancer	0.000416	0.00311	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Dactinomycin—skin cancer	0.000411	0.00307	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00041	0.00306	CcSEcCtD
Mercaptopurine—Vomiting—Imiquimod—skin cancer	0.000402	0.00301	CcSEcCtD
Mercaptopurine—Anorexia—Dactinomycin—skin cancer	0.0004	0.00299	CcSEcCtD
Mercaptopurine—Rash—Imiquimod—skin cancer	0.000399	0.00298	CcSEcCtD
Mercaptopurine—Dermatitis—Imiquimod—skin cancer	0.000399	0.00298	CcSEcCtD
Mercaptopurine—Anaemia—Fluorouracil—skin cancer	0.000396	0.00296	CcSEcCtD
Mercaptopurine—Arthralgia—Temozolomide—skin cancer	0.000396	0.00296	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000393	0.00294	CcSEcCtD
Mercaptopurine—Decreased appetite—Bleomycin—skin cancer	0.000391	0.00292	CcSEcCtD
Mercaptopurine—Stomatitis—Docetaxel—skin cancer	0.000386	0.00288	CcSEcCtD
Mercaptopurine—Leukopenia—Fluorouracil—skin cancer	0.000383	0.00287	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000382	0.00286	CcSEcCtD
Mercaptopurine—Oedema—Temozolomide—skin cancer	0.000379	0.00284	CcSEcCtD
Mercaptopurine—Nausea—Imiquimod—skin cancer	0.000376	0.00281	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Docetaxel—skin cancer	0.000374	0.0028	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Temozolomide—skin cancer	0.000371	0.00278	CcSEcCtD
Mercaptopurine—ABCC4—lymph node—skin cancer	0.000371	0.00659	CbGeAlD
Mercaptopurine—Skin disorder—Temozolomide—skin cancer	0.000368	0.00276	CcSEcCtD
Mercaptopurine—Decreased appetite—Dactinomycin—skin cancer	0.000365	0.00273	CcSEcCtD
Mercaptopurine—Anorexia—Temozolomide—skin cancer	0.000362	0.0027	CcSEcCtD
Mercaptopurine—Body temperature increased—Bleomycin—skin cancer	0.000355	0.00266	CcSEcCtD
Mercaptopurine—Oedema—Fluorouracil—skin cancer	0.00035	0.00261	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000346	0.00258	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Fluorouracil—skin cancer	0.000342	0.00256	CcSEcCtD
Mercaptopurine—Anorexia—Fluorouracil—skin cancer	0.000333	0.00249	CcSEcCtD
Mercaptopurine—Body temperature increased—Dactinomycin—skin cancer	0.000332	0.00248	CcSEcCtD
Mercaptopurine—Hypersensitivity—Bleomycin—skin cancer	0.000331	0.00248	CcSEcCtD
Mercaptopurine—Decreased appetite—Temozolomide—skin cancer	0.00033	0.00247	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000327	0.00245	CcSEcCtD
Mercaptopurine—SLC29A1—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000324	0.0362	CbGpPWpGaD
Mercaptopurine—Immune system disorder—Docetaxel—skin cancer	0.000321	0.0024	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000318	0.00238	CcSEcCtD
Mercaptopurine—Alopecia—Docetaxel—skin cancer	0.000314	0.00235	CcSEcCtD
Mercaptopurine—Malnutrition—Docetaxel—skin cancer	0.000309	0.00231	CcSEcCtD
Mercaptopurine—Hypersensitivity—Dactinomycin—skin cancer	0.000309	0.00231	CcSEcCtD
Mercaptopurine—Decreased appetite—Fluorouracil—skin cancer	0.000304	0.00227	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000302	0.00226	CcSEcCtD
Mercaptopurine—Body temperature increased—Temozolomide—skin cancer	0.0003	0.00224	CcSEcCtD
Mercaptopurine—Diarrhoea—Dactinomycin—skin cancer	0.000287	0.00215	CcSEcCtD
Mercaptopurine—Vomiting—Bleomycin—skin cancer	0.000286	0.00214	CcSEcCtD
Mercaptopurine—Anaemia—Docetaxel—skin cancer	0.000286	0.00214	CcSEcCtD
Mercaptopurine—Rash—Bleomycin—skin cancer	0.000284	0.00212	CcSEcCtD
Mercaptopurine—Dermatitis—Bleomycin—skin cancer	0.000283	0.00212	CcSEcCtD
Mercaptopurine—Hypersensitivity—Temozolomide—skin cancer	0.000279	0.00209	CcSEcCtD
Mercaptopurine—Leukopenia—Docetaxel—skin cancer	0.000277	0.00207	CcSEcCtD
Mercaptopurine—Body temperature increased—Fluorouracil—skin cancer	0.000276	0.00207	CcSEcCtD
Mercaptopurine—SLC29A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000267	0.0298	CbGpPWpGaD
Mercaptopurine—Nausea—Bleomycin—skin cancer	0.000267	0.002	CcSEcCtD
Mercaptopurine—Vomiting—Dactinomycin—skin cancer	0.000267	0.00199	CcSEcCtD
Mercaptopurine—Rash—Dactinomycin—skin cancer	0.000264	0.00198	CcSEcCtD
Mercaptopurine—Arthralgia—Docetaxel—skin cancer	0.000263	0.00197	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000261	0.00195	CcSEcCtD
Mercaptopurine—Diarrhoea—Temozolomide—skin cancer	0.00026	0.00194	CcSEcCtD
Mercaptopurine—SLC28A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000258	0.0288	CbGpPWpGaD
Mercaptopurine—Hypersensitivity—Fluorouracil—skin cancer	0.000257	0.00193	CcSEcCtD
Mercaptopurine—Oedema—Docetaxel—skin cancer	0.000252	0.00189	CcSEcCtD
Mercaptopurine—Nausea—Dactinomycin—skin cancer	0.000249	0.00186	CcSEcCtD
Mercaptopurine—SLC28A3—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000248	0.0277	CbGpPWpGaD
Mercaptopurine—Thrombocytopenia—Docetaxel—skin cancer	0.000247	0.00185	CcSEcCtD
Mercaptopurine—Skin disorder—Docetaxel—skin cancer	0.000245	0.00183	CcSEcCtD
Mercaptopurine—Vomiting—Temozolomide—skin cancer	0.000241	0.0018	CcSEcCtD
Mercaptopurine—Anorexia—Docetaxel—skin cancer	0.00024	0.0018	CcSEcCtD
Mercaptopurine—Rash—Temozolomide—skin cancer	0.000239	0.00179	CcSEcCtD
Mercaptopurine—Diarrhoea—Fluorouracil—skin cancer	0.000239	0.00179	CcSEcCtD
Mercaptopurine—Dermatitis—Temozolomide—skin cancer	0.000239	0.00179	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00023	0.00172	CcSEcCtD
Mercaptopurine—Nausea—Temozolomide—skin cancer	0.000225	0.00168	CcSEcCtD
Mercaptopurine—Vomiting—Fluorouracil—skin cancer	0.000222	0.00166	CcSEcCtD
Mercaptopurine—Rash—Fluorouracil—skin cancer	0.00022	0.00165	CcSEcCtD
Mercaptopurine—Dermatitis—Fluorouracil—skin cancer	0.00022	0.00165	CcSEcCtD
Mercaptopurine—Decreased appetite—Docetaxel—skin cancer	0.000219	0.00164	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000218	0.00163	CcSEcCtD
Mercaptopurine—ABCC5—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000215	0.024	CbGpPWpGaD
Mercaptopurine—Nausea—Fluorouracil—skin cancer	0.000208	0.00155	CcSEcCtD
Mercaptopurine—Body temperature increased—Docetaxel—skin cancer	0.000199	0.00149	CcSEcCtD
Mercaptopurine—ABCC5—Defective B3GAT3 causes JDSSDHD—CSPG4—skin cancer	0.000195	0.0218	CbGpPWpGaD
Mercaptopurine—PPAT—Fluoropyrimidine Activity—TP53—skin cancer	0.000187	0.0209	CbGpPWpGaD
Mercaptopurine—Hypersensitivity—Docetaxel—skin cancer	0.000186	0.00139	CcSEcCtD
Mercaptopurine—SLC29A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000185	0.0207	CbGpPWpGaD
Mercaptopurine—Diarrhoea—Docetaxel—skin cancer	0.000173	0.00129	CcSEcCtD
Mercaptopurine—Vomiting—Docetaxel—skin cancer	0.00016	0.0012	CcSEcCtD
Mercaptopurine—Rash—Docetaxel—skin cancer	0.000159	0.00119	CcSEcCtD
Mercaptopurine—Dermatitis—Docetaxel—skin cancer	0.000159	0.00119	CcSEcCtD
Mercaptopurine—Nausea—Docetaxel—skin cancer	0.00015	0.00112	CcSEcCtD
Mercaptopurine—ABCC4—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000149	0.0166	CbGpPWpGaD
Mercaptopurine—SLC29A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000136	0.0152	CbGpPWpGaD
Mercaptopurine—SLC28A3—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000126	0.0141	CbGpPWpGaD
Mercaptopurine—SLC29A1—Fluoropyrimidine Activity—TP53—skin cancer	0.000116	0.0129	CbGpPWpGaD
Mercaptopurine—ABCC5—Carbohydrate metabolism—CSPG4—skin cancer	0.000105	0.0117	CbGpPWpGaD
Mercaptopurine—SLC29A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	9.41e-05	0.0105	CbGpPWpGaD
Mercaptopurine—SLC22A8—SLC-mediated transmembrane transport—SLC12A2—skin cancer	8.87e-05	0.0099	CbGpPWpGaD
Mercaptopurine—ABCC4—Ectoderm Differentiation—SHH—skin cancer	8.16e-05	0.00911	CbGpPWpGaD
Mercaptopurine—ABCC5—Fluoropyrimidine Activity—TP53—skin cancer	7.66e-05	0.00855	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—PLIN2—skin cancer	7.53e-05	0.0084	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—PLIN2—skin cancer	7.53e-05	0.0084	CbGpPWpGaD
Mercaptopurine—ABCC5—Carbohydrate metabolism—ENO2—skin cancer	7.11e-05	0.00794	CbGpPWpGaD
Mercaptopurine—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	6.65e-05	0.00742	CbGpPWpGaD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—SLC12A2—skin cancer	6.23e-05	0.00696	CbGpPWpGaD
Mercaptopurine—XDH—Selenium Micronutrient Network—PTGS2—skin cancer	6.13e-05	0.00684	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—CSPG4—skin cancer	6.07e-05	0.00677	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—CSPG4—skin cancer	6.07e-05	0.00677	CbGpPWpGaD
Mercaptopurine—ABCC4—Fluoropyrimidine Activity—TP53—skin cancer	5.31e-05	0.00593	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PLIN2—skin cancer	5.3e-05	0.00592	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.51e-05	0.00503	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.32e-05	0.00482	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—CSPG4—skin cancer	4.27e-05	0.00477	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—ENO2—skin cancer	4.12e-05	0.0046	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—ENO2—skin cancer	4.12e-05	0.0046	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PLIN2—skin cancer	3.46e-05	0.00386	CbGpPWpGaD
Mercaptopurine—XDH—Selenium Micronutrient Network—IL6—skin cancer	3.34e-05	0.00373	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CSPG4—skin cancer	3.33e-05	0.00371	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PLIN2—skin cancer	3.21e-05	0.00359	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PLIN2—skin cancer	3.08e-05	0.00344	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CSPG4—skin cancer	2.96e-05	0.00331	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—ENO2—skin cancer	2.91e-05	0.00324	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—CSPG4—skin cancer	2.79e-05	0.00311	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—CSPG4—skin cancer	2.59e-05	0.00289	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—CSPG4—skin cancer	2.48e-05	0.00277	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—ERCC2—skin cancer	2.4e-05	0.00267	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—ERCC2—skin cancer	2.4e-05	0.00267	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—ENO2—skin cancer	2.26e-05	0.00252	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—SHH—skin cancer	2.26e-05	0.00252	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ENO2—skin cancer	2.02e-05	0.00225	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—SHH—skin cancer	2.02e-05	0.00225	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—ENO2—skin cancer	1.89e-05	0.00211	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—FOXO4—skin cancer	1.84e-05	0.00206	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—ENO2—skin cancer	1.76e-05	0.00196	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—ERCC2—skin cancer	1.69e-05	0.00188	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—ENO2—skin cancer	1.69e-05	0.00188	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—FOXO4—skin cancer	1.64e-05	0.00183	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—PTGS2—skin cancer	1.44e-05	0.0016	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—PTGS2—skin cancer	1.44e-05	0.0016	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—ERCC2—skin cancer	1.31e-05	0.00147	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—TERT—skin cancer	1.23e-05	0.00137	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ERCC2—skin cancer	1.17e-05	0.00131	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—ERCC2—skin cancer	1.1e-05	0.00123	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—TERT—skin cancer	1.1e-05	0.00122	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—ERCC2—skin cancer	1.02e-05	0.00114	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PTGS2—skin cancer	1.01e-05	0.00113	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—ERCC2—skin cancer	9.8e-06	0.00109	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—BRAF—skin cancer	9.75e-06	0.00109	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—BRAF—skin cancer	8.69e-06	0.00097	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—PTGS2—skin cancer	7.87e-06	0.000879	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—NRAS—skin cancer	7.82e-06	0.000873	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PTGS2—skin cancer	7.02e-06	0.000783	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—KRAS—skin cancer	6.73e-06	0.000751	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PTGS2—skin cancer	6.59e-06	0.000736	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PTGS2—skin cancer	6.13e-06	0.000684	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—NRAS—skin cancer	6.13e-06	0.000684	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—TP53—skin cancer	5.98e-06	0.000668	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PTGS2—skin cancer	5.88e-06	0.000656	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—HRAS—skin cancer	5.72e-06	0.000638	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—NRAS—skin cancer	5.46e-06	0.000609	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—KRAS—skin cancer	5.27e-06	0.000589	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—KRAS—skin cancer	4.7e-06	0.000525	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—HRAS—skin cancer	4.48e-06	0.0005	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—IL6—skin cancer	4.29e-06	0.000479	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—HRAS—skin cancer	3.99e-06	0.000446	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—IL6—skin cancer	3.82e-06	0.000427	CbGpPWpGaD
